Checkpoint inhibitor doubles 3-year survival rate of BRAF wild-type advanced melanomaOctober 25, 2018Immuno-oncologyMelanoma
ACIP supports hepatitis A vaccine for homeless individualsOctober 24, 2018VaccinesInfectious DiseasesHepatitis